DWA
APYX icon

Dorsey Wright & Associates’s Apyx Medical APYX Stock Holding History

Dorsey Wright & Associates’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,989
Closed -$51K – 284
2021
Q4 		$51K Buy
+3,989
New +$55.8K 0.01% 242
2020
Q2 		– Sell
-1,536
Closed -$6K – 313
2020
Q1 		$6K Hold
1,536
– – ﹤0.01% 235
2019
Q4 		$13K Hold
1,536
– – ﹤0.01% 172
2019
Q3 		$10K Buy
+1,536
New +$10.9K ﹤0.01% 246
2019
Q2 		– Sell
-917
Closed -$6K – 285
2019
Q1 		$6K Buy
+917
New +$7.09K ﹤0.01% 277

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dorsey Wright & Associates's APYX Position: Q1 2022 in Review

Dorsey Wright & Associates sold out of Apyx Medical (APYX) in Q1 2022, closing a stake of 3,989 shares — an estimated $51K sold.

Dorsey Wright & Associates first reported a position in APYX in Q1 2019 and held it in 5 quarters. The position peaked at $51K in Q4 2021. 71 funds tracked by Wall St. Rank hold APYX as of Q1 2022.

  • Dorsey Wright & Associates reported no remaining Apyx Medical position as of Q1 2022 after selling out during the quarter.
  • Dorsey Wright & Associates sold 3,989 Apyx Medical shares in Q1 2022, an estimated $51K.
  • Dorsey Wright & Associates first reported a position in Apyx Medical in Q1 2019 and held it in 5 quarters.
  • Dorsey Wright & Associates's Apyx Medical position peaked at $51K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2022.

Based on Dorsey Wright & Associates's 13F filing for Q1 2022, filed 27 Apr 2022.